Article Details

Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational ...

Retrieved on: 2021-02-24 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational .... View article details on hiswai:

Excerpt

... failed or progressed on CD20-targeted monoclonal antibody therapy. ... drug products such as monoclonal antibodies, clonal master iPSC lines are ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo